AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, C. S.
Right arrow Articles by Sandler, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, C. S.
Right arrow Articles by Sandler, C. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.07.3568
AJR 2008; 191:1220-1232
© American Roentgen Ray Society

Review

Renal Cell Carcinoma: Diagnosis, Staging, and Surveillance

Chaan S. Ng1, Christopher G. Wood2, Paul M. Silverman1, Nizar M. Tannir3, Pheroze Tamboli4 and Carl M. Sandler1

1 Department of Radiology, Box 368, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030-4009.
2 Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
3 Department of Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
4 Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.

OBJECTIVE. This educational review focuses on the staging and radiologic evaluation of renal cell carcinoma. It includes discussion of the epidemiology, pathology, and therapeutic options of renal cell carcinoma and the implications for radiologic follow-up.

CONCLUSION. The incidence of renal cell carinoma has been increasing. Imaging plays a central role in its detection, staging, and treatment evaluation and follow-up.

Keywords: imaging • renal cell carcinoma • staging


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 RadioGraphicsHome page
R. Vikram, C. S. Ng, P. Tamboli, N. M. Tannir, E. Jonasch, S. F. Matin, C. G. Wood, and C. M. Sandler
Papillary Renal Cell Carcinoma: Radiologic-Pathologic Correlation and Spectrum of Disease1
RadioGraphics, May 1, 2009; 29(3): 741 - 754.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.